The announcement of Q1 financial results typically has a significant impact on a company's stock price. Given that Sana Biotechnology's shares are trading lower, it indicates that the market may have reacted negatively to the financial performance reported for the quarter. This could be due to earnings not meeting market expectations or other concerns highlighted in the financial report.